Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Bradykinin B₂ receptor is a G-protein coupled receptor that mediates the effects of bradykinin, a peptide involved in inflammatory pain and other physiological processes. Activation of the B₂ receptor increases the excitability of sensory neurons, contributing to pain perception. It is ubiquitously expressed and represents a potential therapeutic target for pain management and inflammatory conditions.
Gq and Gi protein activation, leading to increased intracellular calcium levels and inhibition of adenylate cyclase. Activation of mitogen-activated protein kinase (MAPK) pathways.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bradykinin B₂ receptor (B2R).